Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Projected CAGR for the GI Stool Testing Market Size from 2025 to 2034?
In recent times, there has been a significant increase in the size of the gi stool testing market. It’s projected to expand from a worth of $1.32 billion in 2024 to a value of $1.41 billion in 2025, at a compound annual growth rate (CAGR) of 6.5%. The driving factors behind this growth in the previous phase include the increased incidence of gastrointestinal diseases, heightened knowledge about the importance of gut health, the rising use of automated systems, an increase in disposable income, and an expanding older population.
In the upcoming years, the gi stool testing market size is anticipated to witness significant expansion, predicted to reach$1.86 billion by 2029″ with a compound annual growth rate (CAGR) of 7.3%. The surge in the market during the forecast period can be credited to the rising demand for effective diagnostic tools, elevated occurrence of colorectal cancer, increased spending on healthcare, higher intake of fast food, and an expanded focus on individualized treatment approaches. Key trends within this forecast period encompass ground-breaking diagnostic methods, molecular diagnostic advances, progression in biologics, tailored medicine, and strategic partnerships.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23410&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of GI Stool Testing Market?
The escalation of gastrointestinal disorders is anticipated to drive the expansion of the GI stool testing market in the future. Gastrointestinal issues are diseases that impact the digestive system, encompassing the stomach, intestines, and associated organs, eliciting symptoms like nausea, diarrhea, constipation, and stomach pain. The hike in gastrointestinal disorders is primarily attributed to substandard dietary practices, as the overconsumption of processed foods, large sugar content, and fiber-deficient diets can interfere with gut microbiota, impair digestive well-being, and feed into disorders like acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). GI stool testing is needed in the case of gastrointestinal disorders to spot infections, inflammations, or digestive imbalances, as it is effective in identifying pathogens (bacteria, viruses, parasites), indicators of gut inflammation, and digestive enzyme insufficiencies, facilitating precise diagnosis and specific treatment. For example, in September 2024, the Centers for Disease Control and Prevention, a government body situated in the US, noted that, between 2024 and 2025, NoroSTAT-involved states reported 1,676 norovirus outbreaks, signaling a stark increase from the 729 outbreaks accounted for during the equivalent period in the previous season. Hence, the escalating prevalence of gastrointestinal disorders is boosting the GI stool testing market’s growth.
Which Key Market Segments Comprise the GI Stool Testing Market and Drive Its Revenue Growth?
The gi stool testingmarket covered in this report is segmented –
1) By Type: Immunoassay Test; Molecular Diagnostic Test; Chromatography-Based Test; Microbiological Culture Test; Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Sample Type: Fecal Samples; Serum Samples
3) By Equipment: Automated Analyzers; Benchtop Instruments; Portable Devices
4) By Application: Diagnosis Of Gastrointestinal Disorders; Screening For Colorectal Cancer; Monitoring Of Inflammatory Bowel Disease (IBD); Detection Of Gastrointestinal Infections; Evaluation Of Digestive Health
5) By End User: Hospital; Diagnostic Centre And Laboratory; Academic Institution; Research Centre Organization; Homecare; Other End Users
Subsegments:
1) By Immunoassay Test: Rapid Immunoassay; Lateral Flow Assay; Fluorescent Immunoassay
2) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Test (NAAT); Next-Generation Sequencing (NGS)
3) By Chromatography-Based Test: Gas Chromatography (GC); Liquid Chromatography (LC); Thin-Layer Chromatography (TLC)
4) By Microbiological Culture Test: Aerobic Culture; Anaerobic Culture; Selective Media Culture
5) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA; Indirect ELISA; Sandwich ELISA; Competitive ELISA
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=23410&type=smp
Which Areas Are Leading Regions in the GI Stool Testing Market Expansion Across the Globe?
North America was the largest region in the GI stool testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gi stool testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the GI Stool Testing Market?
Major firms in the GI stool testing market are targeting more advanced testing technologies like comprehensive diagnostic tests, to enhance precision, speed, and early detection of diseases. Comprehensive diagnostic tests are highly advanced medical tools capable of assessing various health parameters at the same time for a completely thorough evaluation of a condition. For instance, EmeritusDX, a company specializing in diagnostics based in the US, introduced GI Detect in November 2024. GI Detect is an innovative comprehensive diagnostic test built to assist healthcare providers in pinpointing gastrointestinal conditions. The test employs a single stool swab to identify 26 bacteria, viruses, and parasites linked to digestive disturbances, boasting a 24-hour turnaround time, thus facilitating quick and informed medical decisions. Apart from extensive pathogen detection, Helicobacter pylori and its virulence elements—VacA, cagA, and babA—and mainstream gastrointestinal parasites like Cryptosporidium, Entamoeba histolytica, and Giardia lamblia are also screened. This all-encompassing method guarantees correct and timely diagnosis of gastrointestinal infections.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gi-stool-testing-global-market-report
How Is the GI Stool Testing Market Conceptually Defined?
Gastrointestinal (GI) stool testing refers to the analysis of stool samples to assess gastrointestinal health and detect infections, digestive disorders, and inflammatory conditions. It helps identify microbial imbalances, digestive enzyme deficiencies, and markers of gut inflammation. This non-invasive diagnostic method supports early disease detection and personalized treatment planning.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23410
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model